000 01301 a2200349 4500
005 20250515033927.0
264 0 _c20061012
008 200610s 0 0 eng d
022 _a0954-6634
024 7 _a10.1080/09546630600688523
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSantoro, Francesca
245 0 0 _aCutaneous adverse effects during therapy with an epidermal growth factor receptor (EGFR) inhibitor.
_h[electronic resource]
260 _bThe Journal of dermatological treatment
_c2006
300 _a160-1 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAged
650 0 4 _aCarcinoma, Non-Small-Cell Lung
_xdrug therapy
650 0 4 _aDiagnosis, Differential
650 0 4 _aDrug Eruptions
_xdiagnosis
650 0 4 _aErbB Receptors
_xantagonists & inhibitors
650 0 4 _aErlotinib Hydrochloride
650 0 4 _aHumans
650 0 4 _aLung Neoplasms
_xdrug therapy
650 0 4 _aMale
650 0 4 _aProtein Kinase Inhibitors
_xadverse effects
650 0 4 _aQuinazolines
_xadverse effects
700 1 _aCozzani, Emanuele
700 1 _aParodi, Aurora
773 0 _tThe Journal of dermatological treatment
_gvol. 17
_gno. 3
_gp. 160-1
856 4 0 _uhttps://doi.org/10.1080/09546630600688523
_zAvailable from publisher's website
999 _c16445032
_d16445032